Impact of early treatment of psoriasis on disease recurrence – Results from the STEPIn study

Published: 10 February 2026| Version 1 | DOI: 10.17632/8fkgxty3v4.1
Contributors:
Lars Iversen, Richard G. Langley, Johann E. Gudjonsson, Liv Eidsmo, Joanna Narbutt, Rafal Czajkowski, Andreas Pinter, Andrew E. Pink, RAQUEL RIVERA, Frank Kolbinger, Dheeraj A. Gianchandani, Weibin Bao, Corine Gaillez, Piotr Jagiello , Curdin Conrad

Description

STEPIn study evaluated the proportion of patients who maintained sustained skin clearance off-treatment with secukinumab and nb-UVB from week 52 through week 104.

Files

Categories

Dermatology, Psoriasis, Early Intervention

Licence